These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 21862978)

  • 1. Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
    La Thangue NB; Kerr DJ
    Nat Rev Clin Oncol; 2011 Aug; 8(10):587-96. PubMed ID: 21862978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.
    Ong FS; Das K; Wang J; Vakil H; Kuo JZ; Blackwell WL; Lim SW; Goodarzi MO; Bernstein KE; Rotter JI; Grody WW
    Expert Rev Mol Diagn; 2012 Jul; 12(6):593-602. PubMed ID: 22845480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Personalized medicine in oncology].
    Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
    Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New directions in biomarker research, drug development and personalized medicine].
    Németh G; Jelinek I
    Magy Onkol; 2013 Mar; 57(1):5-10. PubMed ID: 23573515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Precision oncology : How can high-quality healthcare remain affordable for all in the face of diagnostic and therapeutic costs?].
    Schlomm T; Rödiger T; Graalmann J
    Urologe A; 2021 Jan; 60(1):3-7. PubMed ID: 33315135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized health care beyond oncology: new indications for immunoassay-based companion diagnostics.
    Batrla R; Jordan BW
    Ann N Y Acad Sci; 2015 Jun; 1346(1):71-80. PubMed ID: 25866164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of precision medicine: towards a more predictive personalized medicine.
    Elemento O
    Emerg Top Life Sci; 2020 Sep; 4(2):175-177. PubMed ID: 32856697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.
    Morand du Puch CB; Vanderstraete M; Giraud S; Lautrette C; Christou N; Mathonnet M
    Theranostics; 2021; 11(19):9538-9556. PubMed ID: 34646385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing precision medicine in a global world.
    Rubin EH; Allen JD; Nowak JA; Bates SE
    Clin Cancer Res; 2014 Mar; 20(6):1419-27. PubMed ID: 24634465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-Oncology in the Era of Personalized Medicine.
    Gwin WR; Disis ML; Ruiz-Garcia E
    Adv Exp Med Biol; 2019; 1168():117-129. PubMed ID: 31713168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostics and personalized medicine: observations from the World Companion Diagnostics Summit.
    Curran ME; Platero S
    Pharmacogenomics; 2011 Apr; 12(4):465-70. PubMed ID: 21521019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Companion and Complementary Diagnostics: Clinical and Regulatory Perspectives.
    Jørgensen JT
    Trends Cancer; 2016 Dec; 2(12):706-712. PubMed ID: 28741518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Implementing Pharmacogenomics Study in Cancer.
    Romero Lagunes ML; Vera Badillo FE
    Adv Exp Med Biol; 2019; 1168():43-77. PubMed ID: 31713164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
    Donovan MJ; Cordon-Cardo C
    Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
    Riedl JM; Moik F; Esterl T; Kostmann SM; Gerger A; Jost PJ
    Virchows Arch; 2024 Feb; 484(2):169-179. PubMed ID: 37982847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.